Global Small Molecule CDMO Market Growth (Status and Outlook) 2023-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,660	124 Pages	LP Information, Inc.	January, 2023	LPI17670110

Best Price Guarantee
Price	from $3,660
Length	124 Pages
Publisher	LP Information, Inc.
Published Date	January, 2023
SKU	LPI17670110

Global Small Molecule CDMO Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Small Molecule CDMO Industry Forecast” looks at past sales and reviews total world Small Molecule CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Small Molecule CDMO sales for 2023 through 2029. With Small Molecule CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule CDMO industry.

This Insight Report provides a comprehensive analysis of the global Small Molecule CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Small Molecule CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule CDMO.

The global Small Molecule CDMO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Small Molecule CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Small Molecule CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Small Molecule CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Small Molecule CDMO players cover Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule CDMO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Development
API Production

Segmentation by application
Pharmaceutical
Biopharmaceutical

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical

Please note: The report will take approximately 2 business days to prepare and deliver.

*This is a tentative TOC and the final deliverable is subject to change.*

1 Scope of the Report: 1.1 Market Introduction; 1.2 Years Considered; 1.3 Research Objectives; 1.4 Market Research Methodology; 1.5 Research Process and Data Source; 1.6 Economic Indicators; 1.7 Currency Considered; 1.8 Market Estimation Caveats
2 Executive Summary: 2.1 World Market Overview; 2.1.1 Global Small Molecule CDMO Market Size 2018-2029; 2.1.2 Small Molecule CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029; 2.2 Small Molecule CDMO Segment by Type; 2.2.1 Development; 2.2.2 API Production; 2.3 Small Molecule CDMO Market Size by Type; 2.3.1 Small Molecule CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029); 2.3.2 Global Small Molecule CDMO Market Size Market Share by Type (2018-2023); 2.4 Small Molecule CDMO Segment by Application; 2.4.1 Pharmaceutical; 2.4.2 Biopharmaceutical; 2.5 Small Molecule CDMO Market Size by Application; 2.5.1 Small Molecule CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029); 2.5.2 Global Small Molecule CDMO Market Size Market Share by Application (2018-2023)
3 Small Molecule CDMO Market Size by Player: 3.1 Small Molecule CDMO Market Size Market Share by Players; 3.1.1 Global Small Molecule CDMO Revenue by Players (2018-2023); 3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2018-2023); 3.2 Global Small Molecule CDMO Key Players Head office and Products Offered; 3.3 Market Concentration Rate Analysis; 3.3.1 Competition Landscape Analysis; 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023); 3.4 New Products and Potential Entrants; 3.5 Mergers & Acquisitions, Expansion
4 Small Molecule CDMO by Regions: 4.1 Small Molecule CDMO Market Size by Regions (2018-2023); 4.2 Americas Small Molecule CDMO Market Size Growth (2018-2023); 4.3 APAC Small Molecule CDMO Market Size Growth (2018-2023); 4.4 Europe Small Molecule CDMO Market Size Growth (2018-2023); 4.5 Middle East & Africa Small Molecule CDMO Market Size Growth (2018-2023)
5 Americas: 5.1 Americas Small Molecule CDMO Market Size by Country (2018-2023); 5.2 Americas Small Molecule CDMO Market Size by Type (2018-2023); 5.3 Americas Small Molecule CDMO Market Size by Application (2018-2023); 5.4 United States; 5.5 Canada; 5.6 Mexico; 5.7 Brazil
6 APAC: 6.1 APAC Small Molecule CDMO Market Size by Region (2018-2023); 6.2 APAC Small Molecule CDMO Market Size by Type (2018-2023); 6.3 APAC Small Molecule CDMO Market Size by Application (2018-2023); 6.4 China; 6.5 Japan; 6.6 Korea; 6.7 Southeast Asia; 6.8 India; 6.9 Australia
7 Europe: 7.1 Europe Small Molecule CDMO by Country (2018-2023); 7.2 Europe Small Molecule CDMO Market Size by Type (2018-2023); 7.3 Europe Small Molecule CDMO Market Size by Application (2018-2023); 7.4 Germany; 7.5 France; 7.6 UK; 7.7 Italy; 7.8 Russia
8 Middle East & Africa: 8.1 Middle East & Africa Small Molecule CDMO by Region (2018-2023); 8.2 Middle East & Africa Small Molecule CDMO Market Size by Type (2018-2023); 8.3 Middle East & Africa Small Molecule CDMO Market Size by Application (2018-2023); 8.4 Egypt; 8.5 South Africa; 8.6 Israel; 8.7 Turkey; 8.8 GCC Countries
9 Market Drivers, Challenges and Trends: 9.1 Market Drivers & Growth Opportunities; 9.2 Market Challenges & Risks; 9.3 Industry Trends
10 Global Small Molecule CDMO Market Forecast: 10.1 Global Small Molecule CDMO Forecast by Regions (2024-2029); 10.1.1 Global Small Molecule CDMO Forecast by Regions (2024-2029); 10.1.2 Americas Small Molecule CDMO Forecast; 10.1.3 APAC Small Molecule CDMO Forecast; 10.1.4 Europe Small Molecule CDMO Forecast; 10.1.5 Middle East & Africa Small Molecule CDMO Forecast; 10.2 Americas Small Molecule CDMO Forecast by Country (2024-2029); 10.2.1 United States Small Molecule CDMO Market Forecast; 10.2.2 Canada Small Molecule CDMO Market Forecast; 10.2.3 Mexico Small Molecule CDMO Market Forecast; 10.2.4 Brazil Small Molecule CDMO Market Forecast; 10.3 APAC Small Molecule CDMO Forecast by Region (2024-2029); 10.3.1 China Small Molecule CDMO Market Forecast; 10.3.2 Japan Small Molecule CDMO Market Forecast; 10.3.3 Korea Small Molecule CDMO Market Forecast; 10.3.4 Southeast Asia Small Molecule CDMO Market Forecast; 10.3.5 India Small Molecule CDMO Market Forecast; 10.3.6 Australia Small Molecule CDMO Market Forecast; 10.4 Europe Small Molecule CDMO Forecast by Country (2024-2029); 10.4.1 Germany Small Molecule CDMO Market Forecast; 10.4.2 France Small Molecule CDMO Market Forecast; 10.4.3 UK Small Molecule CDMO Market Forecast; 10.4.4 Italy Small Molecule CDMO Market Forecast; 10.4.5 Russia Small Molecule CDMO Market Forecast; 10.5 Middle East & Africa Small Molecule CDMO Forecast by Region (2024-2029); 10.5.1 Egypt Small Molecule CDMO Market Forecast; 10.5.2 South Africa Small Molecule CDMO Market Forecast; 10.5.3 Israel Small Molecule CDMO Market Forecast; 10.5.4 Turkey Small Molecule CDMO Market Forecast; 10.5.5 GCC Countries Small Molecule CDMO Market Forecast; 10.6 Global Small Molecule CDMO Forecast by Type (2024-2029); 10.7 Global Small Molecule CDMO Forecast by Application (2024-2029)
11 Key Players Analysis: 11.1 Lonza; 11.1.1 Lonza Company Information; 11.1.2 Lonza Small Molecule CDMO Product Offered; 11.1.3 Lonza Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.1.4 Lonza Main Business Overview; 11.1.5 Lonza Latest Developments; 11.2 Catalent; 11.2.1 Catalent Company Information; 11.2.2 Catalent Small Molecule CDMO Product Offered; 11.2.3 Catalent Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.2.4 Catalent Main Business Overview; 11.2.5 Catalent Latest Developments; 11.3 Thermo Fisher; 11.3.1 Thermo Fisher Company Information; 11.3.2 Thermo Fisher Small Molecule CDMO Product Offered; 11.3.3 Thermo Fisher Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.3.4 Thermo Fisher Main Business Overview; 11.3.5 Thermo Fisher Latest Developments; 11.4 Wuxi Apptec; 11.4.1 Wuxi Apptec Company Information; 11.4.2 Wuxi Apptec Small Molecule CDMO Product Offered; 11.4.3 Wuxi Apptec Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.4.4 Wuxi Apptec Main Business Overview; 11.4.5 Wuxi Apptec Latest Developments; 11.5 PharmaBlock; 11.5.1 PharmaBlock Company Information; 11.5.2 PharmaBlock Small Molecule CDMO Product Offered; 11.5.3 PharmaBlock Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.5.4 PharmaBlock Main Business Overview; 11.5.5 PharmaBlock Latest Developments; 11.6 Asym Chemical; 11.6.1 Asym Chemical Company Information; 11.6.2 Asym Chemical Small Molecule CDMO Product Offered; 11.6.3 Asym Chemical Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.6.4 Asym Chemical Main Business Overview; 11.6.5 Asym Chemical Latest Developments; 11.7 Jiuzhou Pharmaceutical; 11.7.1 Jiuzhou Pharmaceutical Company Information; 11.7.2 Jiuzhou Pharmaceutical Small Molecule CDMO Product Offered; 11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.7.4 Jiuzhou Pharmaceutical Main Business Overview; 11.7.5 Jiuzhou Pharmaceutical Latest Developments; 11.8 Pharmaron Beijing; 11.8.1 Pharmaron Beijing Company Information; 11.8.2 Pharmaron Beijing Small Molecule CDMO Product Offered; 11.8.3 Pharmaron Beijing Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.8.4 Pharmaron Beijing Main Business Overview; 11.8.5 Pharmaron Beijing Latest Developments; 11.9 Porton Pharma; 11.9.1 Porton Pharma Company Information; 11.9.2 Porton Pharma Small Molecule CDMO Product Offered; 11.9.3 Porton Pharma Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.9.4 Porton Pharma Main Business Overview; 11.9.5 Porton Pharma Latest Developments; 11.10 ChemPartner; 11.10.1 ChemPartner Company Information; 11.10.2 ChemPartner Small Molecule CDMO Product Offered; 11.10.3 ChemPartner Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.10.4 ChemPartner Main Business Overview; 11.10.5 ChemPartner Latest Developments; 11.11 Jiangsu Sinopep; 11.11.1 Jiangsu Sinopep Company Information; 11.11.2 Jiangsu Sinopep Small Molecule CDMO Product Offered; 11.11.3 Jiangsu Sinopep Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.11.4 Jiangsu Sinopep Main Business Overview; 11.11.5 Jiangsu Sinopep Latest Developments; 11.12 DELPHARM; 11.12.1 DELPHARM Company Information; 11.12.2 DELPHARM Small Molecule CDMO Product Offered; 11.12.3 DELPHARM Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.12.4 DELPHARM Main Business Overview; 11.12.5 DELPHARM Latest Developments; 11.13 Aenova Group; 11.13.1 Aenova Group Company Information; 11.13.2 Aenova Group Small Molecule CDMO Product Offered; 11.13.3 Aenova Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.13.4 Aenova Group Main Business Overview; 11.13.5 Aenova Group Latest Developments; 11.14 Siegfried Holding AG; 11.14.1 Siegfried Holding AG Company Information; 11.14.2 Siegfried Holding AG Small Molecule CDMO Product Offered; 11.14.3 Siegfried Holding AG Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.14.4 Siegfried Holding AG Main Business Overview; 11.14.5 Siegfried Holding AG Latest Developments; 11.15 Recipharm AB; 11.15.1 Recipharm AB Company Information; 11.15.2 Recipharm AB Small Molecule CDMO Product Offered; 11.15.3 Recipharm AB Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.15.4 Recipharm AB Main Business Overview; 11.15.5 Recipharm AB Latest Developments; 11.16 FAREVA SA; 11.16.1 FAREVA SA Company Information; 11.16.2 FAREVA SA Small Molecule CDMO Product Offered; 11.16.3 FAREVA SA Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.16.4 FAREVA SA Main Business Overview; 11.16.5 FAREVA SA Latest Developments; 11.17 Almac Group; 11.17.1 Almac Group Company Information; 11.17.2 Almac Group Small Molecule CDMO Product Offered; 11.17.3 Almac Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.17.4 Almac Group Main Business Overview; 11.17.5 Almac Group Latest Developments; 11.18 Cambrex; 11.18.1 Cambrex Company Information; 11.18.2 Cambrex Small Molecule CDMO Product Offered; 11.18.3 Cambrex Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.18.4 Cambrex Main Business Overview; 11.18.5 Cambrex Latest Developments; 11.19 Charles River; 11.19.1 Charles River Company Information; 11.19.2 Charles River Small Molecule CDMO Product Offered; 11.19.3 Charles River Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.19.4 Charles River Main Business Overview; 11.19.5 Charles River Latest Developments; 11.20 CORDEN PHARMA; 11.20.1 CORDEN PHARMA Company Information; 11.20.2 CORDEN PHARMA Small Molecule CDMO Product Offered; 11.20.3 CORDEN PHARMA Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.20.4 CORDEN PHARMA Main Business Overview; 11.20.5 CORDEN PHARMA Latest Developments; 11.21 Jubilant Pharmova; 11.21.1 Jubilant Pharmova Company Information; 11.21.2 Jubilant Pharmova Small Molecule CDMO Product Offered; 11.21.3 Jubilant Pharmova Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.21.4 Jubilant Pharmova Main Business Overview; 11.21.5 Jubilant Pharmova Latest Developments; 11.22 Consort Medical; 11.22.1 Consort Medical Company Information; 11.22.2 Consort Medical Small Molecule CDMO Product Offered; 11.22.3 Consort Medical Small Molecule CDMO Revenue, Gross Margin and Market Share (2018-2023); 11.22.4 Consort Medical Main Business Overview; 11.22.5 Consort Medical Latest Developments
12 Research Findings and Conclusion